February 20, 2026
Projections indicate that, the global monoclonal antibodie market will increase from USD 254.89 billion in 2024 to USD 823.31 billion by 2034, experiencing a CAGR of 12.44% over the next 10 years. The monoclonal antibodies market is expanding due t...
November 01, 2025
Based on market forecasts, the monoclonal antibodies therapeutics sector will expand from USD 265.17 billion in 2024 to USD 1057.91 billion by 2034, experiencing a CAGR of 14.84%. In 2024, North America led the monoclonal antibody therapeutics market...
November 01, 2025
Based on market forecasts, the monoclonal antibodies in veterinary health sector will expand from USD 1.23 billion in 2024 to USD 6 billion by 2034, experiencing a CAGR of 17.13%. In 2024, North America led the veterinary monoclonal antibodies market...
February 02, 2026
According to our projections, the biosimilar monoclonal antibodies market is projected to reach USD 19.78 billion in 2026, expanding to approximately USD 129.61 billion by 2035 at a CAGR of 23.23%....
November 01, 2025
Market insights predict, the biologics safety testing industry is expected to grow from USD 4.03 billion in 2024 to USD 14.45 billion by 2034, driven by a CAGR of 13.64%. The growing demand for biologics and growing research and development activitie...
November 01, 2025
Market insights predict, the oncology biosimilars industry is expected to grow from USD 6.7 billion in 2024 to USD 36.23 billion by 2034, driven by a CAGR of 18.47%. The oncology biosimilars market is witnessing rapid growth, offering similar and c...
February 05, 2026
According to our forecasts, the humanized monoclonal antibody market was valued at USD 170.04 billion in 2025 and is projected to reach USD 190.34 billion in 2026, expanding to USD 525.3 billion by 2035 at a CAGR of 11.94% from 2026 to 2035....
February 09, 2026
According to market projections, the monoclonal antibody for asthma and COPD sector is expected to grow from USD 34.02 billion in 2025 to USD 58.94 billion by 2035, reflecting a CAGR of 5.65%, providing detailed analysis of disease-specific segment...
December 18, 2025
According to market projections, the monoclonal antibody discovery platform sector is expected to grow from USD 3.66 billion in 2025 to USD 11.93 billion by 2035, reflecting a CAGR of 12.55% that covers manufacturers, suppliers, value chain insights,...
January 09, 2026
Market insights predict, the antibodies drug industry is expected to grow from USD 272.3 billion in 2025 to USD 759.36 billion by 2035, driven by a CAGR of 10.8%. The increase in the production of monoclonal antibodies is leading to higher demand for...
November 01, 2025
Market insights predict the global research antibodies industry will increase from USD 1.68 billion in 2024 to USD 2.71 billion by 2034, achieving a CAGR of 4.90%. The rising need for high-quality antibodies for repeatable research is one of the main...
November 01, 2025
According to forecasts, the global polyclonal antibodies market will grow from USD 1.68 billion in 2024 to USD 2.74 billion by 2034, with an expected CAGR of 5.04%. Growing cases of diseases is driving the usage of polyclonal antibodies....
November 01, 2025
According to market projections, the global epigenetic antibodies market, valued at USD 2.29 billion in 2024, is anticipated to reach USD 12.01 billion by 2034, growing at a CAGR of 18.04% over the next decade.The epigenetic antibodies market is grow...
+1 9197 992 333
+91 93077 85324
sales@towardshealthcare.com